Search results for: juvenile idiopathic arthritis

Inflammatory Myopathies in Children

Angela Byun Robinson, MD, and Ann M. Reed, MD | July 10, 2012

Treatment options and recent research for juvenile dermatomyositis.

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD | March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

New Approaches to Inflammatory Myopathy

Vanessa Caceres | February 12, 2011

Advances in diagnostic modalities and treatments emerge

For Myopathy Basic Diagnostic Rules Hold

Gretchen Henkel | November 1, 2010

Rare and challenging, idiopathic inflammatory myopathies are gaining from collaborative research

Rehabilitation and Myositis

Michael O. Harris-Love, DSc, MPT | January 1, 2008

Physical therapy to manage inflammatory muscle disease

Myositis Mysteries

Kathleen M. Coyle, MD, Paul H. Plotz, MD, and Mark F. Gourley, MD | January 1, 2008

Why isn’t my myositis patient getting better?

Clinical Cutting Edge

Jane Jerrard | July 1, 2007

Updates on Sjogren’s syndrome, myositis, and vasculitis

The Chimeric Self

J. Lee Nelson, MD, and Anne Stevens, MD, PhD | February 1, 2007

Michrochimerism research offers insights into several autoimmune conditions